Background
The ameloblastoma is the most common neoplasm arising from the primary odontogenic, or tooth forming, tissue. In contrast to squamous cell carcinomas of the oral cavity, which are relatively, common, these tumors are rare. Pathologists who specialize in diagnosing these rare tumors of the oral cavity are called oral pathologists.
These tumors most commonly present with slow growing tumor and are usually asymptomatic until a large size is achieved. These tumors characteristically expand within the jaw and displace bone, teeth, and roots. Occasionally, infiltrating tumors may erode through the bone and extend into the soft tissue. A common scenario is a tumor arising in association with an impacted third molar.
The pathologist's role is to determine whether the tumor is infiltrative. If it is, more aggressive local excision should occur since these tumors may have a history or repeated recurrences.
OUTLINE
EPIDEMIOLOGY CHARACTERIZATION INCIDENCE Most common odontogenic neoplasm AGE RANGE-MEDIAN Mean 33 years SEX (M:F)Equal GEOGRAPHYCaucasians favored
African-Americans
Asians (especially Chinese)
PATHOGENESIS CHARACTERIZATION CHROMOSOMAL ALTERATIONS
- Allelic loss of tumor suppressor genes in ameloblastic tumors.
Nodit L, Barnes L, Childers E, Finkelstein S, Swalsky P, Hunt J.
Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.
Mod Pathol. 2004 Sep;17(9):1062-7. Related Articles, Links
Ameloblastoma is an odontogenic tumor with a variety of histologic appearances and an unpredictable biologic behavior. Little is known about allelic losses of tumor suppressor genes in ameloblastomas.
This study surveyed DNA damage in ameloblastomas and correlated this with histologic sub-type and clinical outcome. There were 12 ameloblastomas (two peripheral, eight solid, and two unicystic) and three ameloblastic carcinoma studied for loss of heterozygosity of tumor suppressor genes on chromosomes 1p, 3p, 9p,10q, and 17p (L-myc, hOGG1, p16, pten, and p53). The frequency of allelic loss and the intratumoral heterogeneity were calculated. L-myc (71% frequency of allelic loss) and pten (62% frequency of allelic loss) had the most frequent allelic losses.
Overall frequency of allelic loss and intratumoral heterogeneity were higher in mandibular and in unicystic tumors and lower in tumors that recurred/metastasized. The rate of allelic loss in the three carcinomas was similar to that seen in benign tumors. The frequency of allelic loss and intratumoral heterogeneity did not correlate with age, gender, histologic subtype, or prognosis. Since tumors that behaved aggressively did not harbor more allelic losses, it is likely that DNA damage in ameloblastomas and ameloblastic carcinomas is sporadic and cumulative.
We conclude that other genetic or epigenetic mechanisms may be responsible for malignant behavior in ameloblastic carcinomas.HUMAN PAPILLOMA VIRUS
- Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection.
Migaldi M, Pecorari M, Rossi G, Maiorana A, Bettelli S, Tamassia MG, De Gaetani C, Leocata P, Portolani M.
1Department of Pathologic Anatomy and Legal Medicine, Section of Pathology, University of Modena and Reggio Emilia, Modena, Italy.
Mod Pathol. 2005;18:283-289 Abstract quote
Ameloblastomas are epithelial tumors of odontogenic origin, biologically characterized by local recurrence. Among different etiologic factors, HPV infection has been recently postulated to be somehow involved in ameloblastoma etiopathogenesis.
To address this issue, we studied 18 ameloblastomas by means of immunohistochemistry, in situ hybridization (conventional and amplified), polymerase chain reaction and nested-polymerase chain reaction analyses using laser capture microdissection in order to detect the occurrence of HPV in this setting. No evidence of HPV infection was detected by morphological examination, immunohistochemistry, in situ hybridization and conventional polymerase chain reaction, while nested-polymerase chain reaction showed a weak positive band in two cases. However, the subsequent restriction enzyme analysis carried out from the nested-polymerase chain reaction amplification products of these two samples excluded the presence of HPV subtypes 16, 18, 31, 33, 35, 52, and 58. The search for HPV 6 and 11 in the same specimens was also negative.
In conclusion, our data do not support an etiopathogenetic evidence for HPV in ameloblastoma.
SPECIAL STAINS/
IMMUNOPEROXIDASECHARACTERIZATION Epithelium Cytokeratin positive Type IV collagen Identified in desmoplastic tumors
Sem Diagn Pathol 1999;16:271-287.
Henry JB. Clinical Diagnosis and Management by Laboratory Methods. Twentieth Edition. WB Saunders. 2001.
Rosai J. Ackerman's Surgical Pathology. Ninth Edition. Mosby 2004.
Sternberg S. Diagnostic Surgical Pathology. Fourth Edition. Lipincott Williams and Wilkins 2004.
Robbins Pathologic Basis of Disease. Seventh Edition. WB Saunders 2005.
DeMay RM. The Art and Science of Cytopathology. Volume 1 and 2. ASCP Press. 1996.
Weedon D. Weedon's Skin Pathology Second Edition. Churchill Livingstone. 2002
Fitzpatrick's Dermatology in General Medicine. 5th Edition. McGraw-Hill. 1999.
Weiss SW and Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. Fourth Edition. Mosby 2001.
Basic Principles of Disease
Learn the basic disease classifications of cancers, infections, and inflammation
Commonly Used Terms
This is a glossary of terms often found in a pathology report.Diagnostic Process
Learn how a pathologist makes a diagnosis using a microscopeSurgical Pathology Report
Examine an actual biopsy report to understand what each section meansSpecial Stains
Understand the tools the pathologist utilizes to aid in the diagnosisHow Accurate is My Report?
Pathologists actively oversee every area of the laboratory to ensure your report is accurateGot Path?
Recent teaching cases and lectures presented in conferences
Last Updated February 4, 2005
Send mail to The Doctor's Doctor with questions or comments about this web site.
Read the Medical Disclaimer.
Copyright © The Doctor's Doctor